Cabbage fat-burning soup has been a go-to meal for those looking to shed a few pounds while still enjoying a satisfying ...

(Reuters) -Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Echoing Iselin's assessment, Fallon Health CEO Manny Lopes said both providers and payers are at a "crisis point." Meanwhile, ...

Ferreira, who is 43 years old, pointed out that losing weight doesn’t get any easier with age. “Factor in genetics, surgeries ...

Police boats have returned to the Potomac River as part of the recovery and investigation after the United States’ deadliest ...